111 related articles for article (PubMed ID: 4632415)
1. Pre-irradiation qualities of a parotid gland predicting the grade of functional disturbance by radiotherapy.
Eneroth CM; Henrikson CO; Jakobsson PA
Acta Otolaryngol; 1972 Dec; 74(6):436-44. PubMed ID: 4632415
[No Abstract] [Full Text] [Related]
2. Effect of fractionated radiotherapy on salivary gland function.
Eneroth CM; Henrikson CO; Jakobsson PA
Cancer; 1972 Nov; 30(5):1147-53. PubMed ID: 5083053
[No Abstract] [Full Text] [Related]
3. Parotid sialometry--a functional study of the parotid gland in pre- and post-irradiation head and neck cancers.
Dutta TK; Bhattacharjee TK; Gupta BD; Popli SP
Indian J Med Sci; 1973 Jun; 27(6):461-4. PubMed ID: 4756224
[No Abstract] [Full Text] [Related]
4. The effect of irradiation in high doses on parotid glands.
Eneroth CM; Henrikson CO; Jakobsson PA
Acta Otolaryngol; 1971 Apr; 71(4):349-56. PubMed ID: 5574311
[No Abstract] [Full Text] [Related]
5. Proceedings: Electron beam therapy of head and neck tumors.
Tobin DA; Byrd SL; Scott RM
Am J Roentgenol Radium Ther Nucl Med; 1974 Mar; 120(3):617-23. PubMed ID: 4206067
[No Abstract] [Full Text] [Related]
6. Analysis of the Parotid Glands on an Energy Spectrum CT Iodine Map to Evaluate Irradiation-Induced Acute Xerostomia in Patients With Nasopharyngeal Carcinoma.
Chen R; Xie J; Chen J; Li X; Lin Q; Xu Q; Chen Y; Wang L; Zheng R; Xu B
Technol Cancer Res Treat; 2024; 23():15330338241256814. PubMed ID: 38773777
[No Abstract] [Full Text] [Related]
7. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy.
Jen YM; Shih R; Lin YS; Su WF; Ku CH; Chang CS; Shueng PW; Hwang JM; Liu DW; Chao HL; Lin HY; Chang LP; Shum WY; Lin CS
Radiother Oncol; 2005 May; 75(2):204-9. PubMed ID: 15908027
[TBL] [Abstract][Full Text] [Related]
8. The capacity of the parotid glands to concentrate 99mTc from plasma, used as a function test.
Eneroth CM; Henriksson CO; Lind MG
Int J Oral Surg; 1972; 1(6):290-6. PubMed ID: 4203645
[No Abstract] [Full Text] [Related]
9. Acute reaction and late damage of the normal tissue in cancer patients given a dynamic dose-fractionation under breathing of oxygen.
Siracká E; Durkovský J; Jancina J; Révész L
Neoplasma; 1973; 20(6):643-53. PubMed ID: 4773312
[No Abstract] [Full Text] [Related]
10. Temporal Evolution of Parotid Volume and Parotid Apparent Diffusion Coefficient in Nasopharyngeal Carcinoma Patients Treated by Intensity-Modulated Radiotherapy Investigated by Magnetic Resonance Imaging: A Pilot Study.
Juan CJ; Cheng CC; Chiu SC; Jen YM; Liu YJ; Chiu HC; Kao HW; Wang CW; Chung HW; Huang GS; Hsu HH
PLoS One; 2015; 10(8):e0137073. PubMed ID: 26323091
[TBL] [Abstract][Full Text] [Related]
11. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer.
Cannon DM; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):660-5. PubMed ID: 18037580
[TBL] [Abstract][Full Text] [Related]
12. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the parotid function in nasopharyngeal carcinoma treated with parotid-sparing radiotherapy.
Liu WS; Lee SP; Lee JK; Su MC; Chen GD; Lee HS; Lee H
Jpn J Clin Oncol; 2006 Oct; 36(10):626-31. PubMed ID: 17008345
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.
Kam MK; Chau RM; Suen J; Choi PH; Teo PM
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):145-57. PubMed ID: 12694833
[TBL] [Abstract][Full Text] [Related]
15. The management of radiation caries.
Coffin F
Br J Oral Surg; 1973 Jul; 11(1):54-9. PubMed ID: 4200354
[No Abstract] [Full Text] [Related]
16. Texture analysis for the assessment of structural changes in parotid glands induced by radiotherapy.
Scalco E; Fiorino C; Cattaneo GM; Sanguineti G; Rizzo G
Radiother Oncol; 2013 Dec; 109(3):384-7. PubMed ID: 24183861
[TBL] [Abstract][Full Text] [Related]
17. 3D MR sialography as a tool to investigate radiation-induced xerostomia: feasibility study.
Astreinidou E; Roesink JM; Raaijmakers CP; Bartels LW; Witkamp TD; Lagendijk JJ; Terhaard CH
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1310-9. PubMed ID: 17482767
[TBL] [Abstract][Full Text] [Related]
18. Clinical dose-response curves of human malignant epithelial tumours.
Fletcher GH
Br J Radiol; 1973 Jan; 46(541):1-12. PubMed ID: 4630323
[No Abstract] [Full Text] [Related]
19. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy.
Lee TF; Fang FM
Radiother Oncol; 2013 Mar; 106(3):352-8. PubMed ID: 23333019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
